Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial.

Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.

Metadata

Authors/Creators:

Williams, C. https://orcid.org/0000-0002-1574-653X
Seligmann, J.F. https://orcid.org/0000-0003-4379-6005
Guetter, C.
Zhang, L.
Yan, D.
Muranyi, A.
Bai, I.
Singh, S.
Elliott, F.
Shires, M. https://orcid.org/0000-0003-0904-6200
Richman, S. https://orcid.org/0000-0003-3993-5041
West, N. https://orcid.org/0000-0002-0346-6709
Barrett, J.
Seymour, M.T. https://orcid.org/0000-0002-2441-9629
Quirke, P. https://orcid.org/0000-0002-3597-5444
Shanmugam, K.

Dates:

Published (online): 22 January 2021
Published: 20 January 2021

Institution:

The University of Leeds

Academic Units:

The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Pathology and Data Analytics

Funding Information:

Funder	Grant number
Innovate UK fka Technology Strategy Board (TSB)	TS/S012702/1 104687
Cancer Research UK Supplier No: 138573	C6003/A6407
Cancer Research UK Supplier No: 138573	C6003/A7367
Bousfield Holdings Ltd	C6003/A6407
Amgen Limited *USE 819922*	NOT GIVEN
Cancer Research UK Supplier No: 138573	C6003/A15546
Leeds Teaching Hospitals Charitable Foundation	4616
Cancer Research UK Supplier No: 138573	C7852/A19772
Leeds Hospitals Charity	1T01-A321

Depositing User:

Symplectic Publications

Date Deposited:

11 Dec 2023 10:02

Last Modified:

11 Dec 2023 10:02

Status:

Published

Publisher:

American Society of Clinical Oncology

Identification Number:

https://doi.org/10.1200/jco.2021.39.3_suppl.111

CORE (COnnecting REpositories)

Metadata

Download not available

Export

Statistics